Molecular signature of salivary gland tumors: potential use as diagnostic and prognostic marker
- PMID: 25990369
- DOI: 10.1111/jop.12329
Molecular signature of salivary gland tumors: potential use as diagnostic and prognostic marker
Abstract
Salivary gland tumors are a highly heterogeneous group of lesions with diverse microscopic appearances and variable clinical behavior. The use of clinical and histological parameters to predict patient prognosis and survival rates has been of limited utility, and the search for new biomarkers that could not only aid in a better understanding of their pathogenesis but also be reliable auxiliaries for prognostic determination and useful diagnostic tools has been performed in the last decades with very exciting results. Hence, gene rearrangements such as CRTC1-MAML2 in mucoepidermoid carcinomas have shown excellent specificity, and more than that, it has been strongly correlated with low-grade tumors and consequently with an increased survival rate and better prognosis of patients affected by neoplasms carrying this translocation. Moreover, MYB-NFIB and EWSR1-ATF1 gene fusions were shown to be specifically found in cases of adenoid cystic carcinomas and hyalinizing clear cell carcinomas, respectively, in the context of salivary gland tumors, becoming reliable diagnostic tools for these entities and potential therapeutic targets for future therapeutic protocols. Finally, the identification of ETV6-NTRK3 in cases previously diagnosed as uncommon acinic cell carcinomas, cystadenocarcinomas, and adenocarcinomas not otherwise specified led to the characterization of a completely new and now widely accepted entity, including, therefore, mammary analogue secretory carcinoma in the list of well-recognized salivary gland carcinomas. Thus, further molecular investigations of salivary gland tumors are warranted, and the recognition of other genetic abnormalities can lead to the acknowledgment of new entities and the acquirement of reliable biomarkers.
Keywords: CRTC1-MAML2; ETV6-NTRK3; EWSR1-ATF1; MYB-NFIB; salivary gland tumor.
© 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
Similar articles
-
Molecular Pathology of Salivary Gland Neoplasms: Diagnostic, Prognostic, and Predictive Perspective.Adv Anat Pathol. 2021 Mar 1;28(2):81-93. doi: 10.1097/PAP.0000000000000291. Adv Anat Pathol. 2021. PMID: 33405400 Review.
-
The Role of Molecular Testing in the Differential Diagnosis of Salivary Gland Carcinomas.Am J Surg Pathol. 2018 Feb;42(2):e11-e27. doi: 10.1097/PAS.0000000000000980. Am J Surg Pathol. 2018. PMID: 29076877 Review.
-
[New developments in molecular diagnostics of carcinomas of the salivary glands: "translocation carcinomas"].Cesk Patol. 2016;52(3):139-45. Cesk Patol. 2016. PMID: 27526014 Review. Czech.
-
Utility of mammaglobin immunohistochemistry as a proxy marker for the ETV6-NTRK3 translocation in the diagnosis of salivary mammary analogue secretory carcinoma.Hum Pathol. 2013 Oct;44(10):1982-8. doi: 10.1016/j.humpath.2013.03.017. Epub 2013 Jun 14. Hum Pathol. 2013. PMID: 23773480 Free PMC article.
-
Salivary Gland Neoplasms: Does Morphological Diversity Reflect Tumor Heterogeneity.Pathobiology. 2018;85(1-2):85-95. doi: 10.1159/000479070. Epub 2017 Sep 21. Pathobiology. 2018. PMID: 28930752
Cited by
-
Fusion proteins in head and neck neoplasms: Clinical implications, genetics, and future directions for targeting.Cancer Biol Ther. 2016 Oct 2;17(10):995-1002. doi: 10.1080/15384047.2016.1219823. Epub 2016 Sep 16. Cancer Biol Ther. 2016. PMID: 27636353 Free PMC article.
-
DNA mismatch repair system expression in salivary gland tumors: A Systematic Review.Med Oral Patol Oral Cir Bucal. 2024 Sep 1;29(5):e655-e664. doi: 10.4317/medoral.26647. Med Oral Patol Oral Cir Bucal. 2024. PMID: 38907641 Free PMC article.
-
The Challenge of "Monomorphic" Mucoepidermoid Carcinoma-Report of a Rare Case with Pure Spindle-Clear Cell Morphology.Head Neck Pathol. 2023 Sep;17(3):864-870. doi: 10.1007/s12105-023-01547-9. Epub 2023 Apr 4. Head Neck Pathol. 2023. PMID: 37014573 Free PMC article.
-
A multiplex preclinical model for adenoid cystic carcinoma of the salivary gland identifies regorafenib as a potential therapeutic drug.Sci Rep. 2017 Sep 12;7(1):11410. doi: 10.1038/s41598-017-11764-2. Sci Rep. 2017. PMID: 28900283 Free PMC article.
-
Comparison of Peptidomes Extracted from Healthy Tissue and Tumor Tissue of the Parotid Glands and Saliva Samples.Int J Mol Sci. 2024 Aug 13;25(16):8799. doi: 10.3390/ijms25168799. Int J Mol Sci. 2024. PMID: 39201484 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical